Reunion Neuroscience (TSX:REUN) Days Sales Outstanding : 0.00 (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Days Sales Outstanding?

Reunion Neuroscience's average Accounts Receivable for the three months ended in Mar. 2023 was C$0.00 Mil. Reunion Neuroscience's Revenue for the three months ended in Mar. 2023 was C$0.00 Mil.

The historical rank and industry rank for Reunion Neuroscience's Days Sales Outstanding or its related term are showing as below:

TSX:REUN's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 71.03
* Ranked among companies with meaningful Days Sales Outstanding only.

Reunion Neuroscience's Days Sales Outstanding stayed the same from Mar. 2022 (0.00) to Mar. 2023 (0.00).

Reunion Neuroscience Days Sales Outstanding Historical Data

The historical data trend for Reunion Neuroscience's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Days Sales Outstanding Chart

Reunion Neuroscience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

4,380.00

6.27

Reunion Neuroscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Sales Outstanding	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Reunion Neuroscience's Days Sales Outstanding

For the Biotechnology subindustry, Reunion Neuroscience's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reunion Neuroscience's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reunion Neuroscience's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Reunion Neuroscience's Days Sales Outstanding falls into.

Reunion Neuroscience Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Reunion Neuroscience's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0.25	+	0)	/	1 )	/	0	*	365
=	0.25					/	0	*	365
=	N/A

Reunion Neuroscience's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

	Days Sales Outstanding (Q: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Reunion Neuroscience (TSX:REUN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Reunion Neuroscience Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Reunion Neuroscience (TSX:REUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3

Website

https://www.reunionneuro.com

Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.